Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 33Multiple Myeloma 30Lymphoma, Non-Hodgkin 29Hodgkin Disease 28Graft vs Host Disease 26Leukemia, Lymphocytic, Chronic, B-Cell 25Lymphoma 24Leukemia 24Hematologic Neoplasms 20Neoplasms 18Lymphoma, Mantle-Cell 18Sarcoma 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Breast Neoplasms 17Tuberous Sclerosis 15Myeloproliferative Disorders 15Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 14Burkitt Lymphoma 14Waldenstrom Macroglobulinemia 13Lymphoma, B-Cell, Marginal Zone 13Recurrence 12Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 12Prostatic Neoplasms 11Primary Myelofibrosis 11Melanoma 11Leukemia, Myelomonocytic, Chronic 11

Interventions

Sirolimus 4LY3295668 erbumine 3Everolimus 3Anticonvulsants 2perampanel 1clevidipine 1brivaracetam 1Vigabatrin 1Topotecan 1Therapeutic Touch 1Temozolomide 1TAS-119 1Sulfasalazine 1Sevoflurane 1Saline Solution 1Radiotherapy 1Propofol 1Paclitaxel 1Nitrous Oxide 1Midazolam 1Memantine 1Medical Marijuana 1Lidocaine 1Levetiracetam 1Ketamine 1Immunoglobulins, Intravenous 1Glycopyrrolate 1Gabapentin 1Fluid Therapy 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Epilepsy × Sirolimus × Clear all
NCT05104983 2026-01-22

TSC-STEPS

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
64 enrolled

Epilepsy, Tuberous Sclerosis

NCT04595513 2024-05-16

STOP2

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed
5 enrolled 15 charts

Epilepsy, Tuberous Sclerosis

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Unknown
60 enrolled

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT05534672 2023-08-08

RaRE-TS

Children's Memorial Health Institute, Poland

Phase 3 Recruiting
200 enrolled

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡